Effectiveness and tolerability of cannabidiol in paediatric epilepsy: a one-year multisite prospective study
Open Access
- 20 May 2026
- journal article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 182, 111095
Abstract
No abstract availableKeywords
Funding Information
- Department of Health, State Government of Victoria
This publication has 30 references indexed in Scilit:
- Long‐term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3‐year results from the cannabidiol expanded access programEpilepsia Open, 2024
- Real-Life Experience With Purified Cannabidiol Treatment for Refractory Epilepsy: A Multicenter Retrospective StudyPediatric Neurology, 2023
- Real‐world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter studyEpilepsia Open, 2023
- Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysisExperimental Neurology, 2022
- Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis ComplexJAMA Neurology, 2021
- Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet SyndromeJAMA Neurology, 2020
- Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program resultsEpilepsy Research, 2019
- Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-AnalysisDrugs, 2018
- CBD-enriched medical cannabis for intractable pediatric epilepsySeizure: European Journal of Epilepsy, 2016
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008